CureVac N.V. (CVAC)
CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy. The company was founded by Ingmar Hoerr and Florian von der Mülbe in 2000 and is headquartered in Tübingen, Germany.
Address
PAUL-EHRLICH-STRABE 15 TUBINGEN
BADEN-WURTTEMBERG, 2M 72076
Founded
2020
Number of Employees
1,172
Website
http://www.curevac.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)